Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains

[1]  C. Lyketsos,et al.  Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia , 2015, Alzheimer's Research & Therapy.

[2]  M. Sabbagh,et al.  Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire , 2015, Alzheimer's Research & Therapy.

[3]  Vootele Voikar,et al.  Spontaneous behavior in the social homecage discriminates strains, lesions and mutations in mice , 2014, Journal of Neuroscience Methods.

[4]  Paulin Jirkof,et al.  Burrowing and nest building behavior as indicators of well-being in mice , 2014, Journal of Neuroscience Methods.

[5]  M. Staufenbiel,et al.  Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein , 2013, Science Translational Medicine.

[6]  G. Rogler,et al.  Burrowing is a sensitive behavioural assay for monitoring general wellbeing during dextran sulfate sodium colitis in laboratory mice , 2013, Laboratory animals.

[7]  D. Borchelt,et al.  Normal cognition in transgenic BRI2-Aβ mice , 2013, Molecular Neurodegeneration.

[8]  D. Borchelt,et al.  Thinking laterally about neurodegenerative proteinopathies. , 2013, The Journal of clinical investigation.

[9]  Malaz Boustani,et al.  Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting , 2013, Alzheimer's & Dementia.

[10]  D. Borchelt,et al.  Reversible Pathologic and Cognitive Phenotypes in an Inducible Model of Alzheimer-Amyloidosis , 2013, The Journal of Neuroscience.

[11]  K. Blennow,et al.  Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[12]  Jeffrey Cummings,et al.  Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials. , 2012, Archives of neurology.

[13]  D. Dickson,et al.  Age-related increase in amyloid plaque burden is associated with impairment in conditioned fear memory in CRND8 mouse model of amyloidosis , 2012, Alzheimer's Research & Therapy.

[14]  L. D’Adamio,et al.  Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia , 2012, Molecular Neurodegeneration.

[15]  L. D’Adamio,et al.  Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia , 2012, Molecular Neurodegeneration.

[16]  Y. Shitaka,et al.  Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice , 2012, The Journal of Neuroscience.

[17]  M. Gallagher,et al.  Episodic Memory on the Path to Alzheimer's Disease This Review Comes from a Themed Issue on Neurobiology of Disease Edited , 2022 .

[18]  Kimberly Scearce-Levie,et al.  Animal Models of Alzheimer's Disease: Modeling Targets, Not Disease Accelerating Drug Discovery for Alzheimer's Disease: Best Practices for Preclinical Animal Studies , 2022 .

[19]  Marie-Christine Pardon,et al.  A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease , 2011, Behavioural Brain Research.

[20]  Jiejing Xu,et al.  Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer’s disease , 2011, Neuroscience Bulletin.

[21]  E. Sibille,et al.  Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex , 2011, Journal of Neuroscience Methods.

[22]  C. Janus,et al.  Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy , 2011, Neurobiology of Aging.

[23]  Todd E. Golde,et al.  Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift , 2011, Neuron.

[24]  B. Hyman,et al.  Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice , 2010, Neurobiology of Aging.

[25]  K. Zahs,et al.  ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? , 2010, Trends in Neurosciences.

[26]  Courtney A Miller,et al.  Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease , 2010, Neuropsychopharmacology.

[27]  D. Dickson,et al.  Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Michael S. Fanselow,et al.  From contextual fear to a dynamic view of memory systems , 2010, Trends in Cognitive Sciences.

[29]  Phillip B. Jones,et al.  A Reporter of Local Dendritic Translocation Shows Plaque- Related Loss of Neural System Function in APP-Transgenic Mice , 2009, The Journal of Neuroscience.

[30]  C. Eckman,et al.  Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice , 2009, Genes, brain, and behavior.

[31]  Robert Lalonde,et al.  Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease , 2009, Brain Research.

[32]  T. O'Leary,et al.  Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease , 2009, Behavioural Brain Research.

[33]  Sylvain Rheims,et al.  Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.

[34]  M. Day,et al.  Correlating Efficacy in Rodent Cognition Models with in Vivo 5-Hydroxytryptamine1A Receptor Occupancy by a Novel Antagonist, (R)-N-(2-Methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane Carboxamide (WAY-101405) , 2008, Journal of Pharmacology and Experimental Therapeutics.

[35]  G. Frisoni,et al.  MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study , 2008, Neurobiology of Aging.

[36]  Aimée A. Wong,et al.  Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice , 2007, Neurobiology of Aging.

[37]  V. Baumans,et al.  Impact of 'living apart together' on postoperative recovery of mice compared with social and individual housing , 2007, Laboratory animals.

[38]  J. George,et al.  Cognitive assessment in the elderly: a review of clinical methods. , 2007, QJM : monthly journal of the Association of Physicians.

[39]  T. Comery,et al.  The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease , 2007, Molecular and Cellular Neuroscience.

[40]  J. Collinge,et al.  Targeting Cellular Prion Protein Reverses Early Cognitive Deficits and Neurophysiological Dysfunction in Prion-Infected Mice , 2007, Neuron.

[41]  M. Jung,et al.  Neural circuits and mechanisms involved in Pavlovian fear conditioning: A critical review , 2006, Neuroscience & Biobehavioral Reviews.

[42]  Jonathan J. Evans,et al.  A review of screening tests for cognitive impairment , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  R. Deacon.  Assessing nest building in mice , 2006, Nature Protocols.

[44]  Inga Kadish,et al.  Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice , 2006, Neurobiology of Disease.

[45]  R. E. Brown,et al.  Visual detection, pattern discrimination and visual acuity in 14 strains of mice , 2006, Genes, brain, and behavior.

[46]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[47]  D. Borchelt,et al.  Environmental Enrichment Mitigates Cognitive Deficits in a Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[48]  C. Janus.  Search strategies used by APP transgenic mice during navigation in the Morris water maze. , 2004, Learning & memory.

[49]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[50]  D. Borchelt,et al.  Environmental Enrichment Exacerbates Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease , 2003, Journal of neuropathology and experimental neurology.

[51]  S. Noy,et al.  The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients , 2002, International journal of geriatric psychiatry.

[52]  K. Ashe.  Learning and memory in transgenic mice modeling Alzheimer's disease. , 2001, Learning & memory.

[53]  D. Westaway,et al.  Transgenic mouse models of Alzheimer's disease , 2001, Physiology & Behavior.

[54]  M. Pahor,et al.  Assessment of physical function in aging rodents: a strategy for improving preclinical testing. , 2001, Experimental aging research.

[55]  M. Albert,et al.  Preclinical prediction of AD using neuropsychological tests , 2001, Journal of the International Neuropsychological Society.

[56]  D. Borchelt,et al.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. , 2001, Biomolecular engineering.

[57]  Y. Tasaki,et al.  β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease , 2001, Neuroscience.

[58]  M. Staufenbiel,et al.  Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.

[59]  Glen T Prusky,et al.  Reduced visual acuity impairs place but not cued learning in the Morris water task , 2000, Behavioural Brain Research.

[60]  R. Douglas,et al.  Behavioral assessment of visual acuity in mice and rats , 2000, Vision Research.

[61]  B. Ott,et al.  Cognition and behavior in patients with Alzheimer's disease. , 1999, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[62]  David P. Wolfer,et al.  Spatial Memory and Learning in Transgenic Mice: Fact or Artifact? , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[63]  R. Petersen,et al.  Aging, Memory, and Mild Cognitive Impairment , 1997, International Psychogeriatrics.

[64]  J. Powers,et al.  Diagnostic Criteria for the Neuropathologic Assessment of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[65]  R. Paylor,et al.  Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. , 1997, Behavioral neuroscience.

[66]  M. Oscar-Berman,et al.  Memory deficits in Alzheimer's patients: A comprehensive review , 1992, Neuropsychology Review.

[67]  M. Fanselow.  Factors governing one-trial contextual conditioning , 1990 .

[68]  A. Burns,et al.  Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.

[69]  R. Lévy,et al.  Psychiatric Phenomena in Alzheimer's Disease. IV: Disorders of Behaviour , 1990, British Journal of Psychiatry.

[70]  A. Burns,et al.  Psychiatric Phenomena in Alzheimer's Disease. II: Disorders of Perception , 1990, British Journal of Psychiatry.

[71]  A. Burns,et al.  Psychiatric Phenomena in Alzheimer's Disease. III: Disorders of Mood , 1990, British Journal of Psychiatry.

[72]  D. Treit,et al.  Thigmotaxis as a test for anxiolytic activity in rats , 1988, Pharmacology Biochemistry and Behavior.

[73]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[74]  B. Dudek,et al.  Genetic influences on digging behaviors in mice (Mus musculus) in laboratory and seminatural settings. , 1983, Journal of comparative psychology.

[75]  F. Vogel,et al.  The limbic system in Alzheimer's disease. A neuropathologic investigation. , 1976, The American journal of pathology.

[76]  H. Welzl,et al.  Mouse models of neurodegenerative diseases: criteria and general methodology. , 2010, Methods in molecular biology.

[77]  C. Janus,et al.  Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration , 2007, Behavior genetics.

[78]  R. Deacon.  Burrowing in rodents: a sensitive method for detecting behavioral dysfunction , 2006, Nature Protocols.

[79]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[80]  D. Borchelt,et al.  Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. , 2004, Human molecular genetics.

[81]  D. German,et al.  Mouse Models of Alzheimer's Disease: Insight into Treatment , 2004, Reviews in the neurosciences.

[82]  Y. Tasaki,et al.  beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. , 2001, Neuroscience.

[83]  Ove Almkvist,et al.  Early diagnosis of Alzheimer dementia based on clinical and biological factors , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[84]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .

[85]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .